Nuvectis reports Q3 2026 results, advances ciprocopan and NXP200 toward US filingsNov 4Quarterly updateNuvectis Pharma, Inc.
AstraZeneca completes balcinrenone/dapagliflozin PK study; posts two new observational trialsOct 23Weekly roundup, 12 itemsabemaciclibAstraZeneca
CHMP backs two AstraZeneca drugs: Klygefa in gMG, Enhertu in early breast cancerSep 21Regulatory milestoneAstraZenecafam-trastuzumab deruxtecan-nxki
AstraZeneca posts Phase 3 LOGOS, KALOS asthma results; updates Soliris labelJul 2Weekly roundup, 5 itemsAstraZenecaAZD4045
Amgen recalls Sensipar and Corlanor lots; BKEMV biosimilar gets label updateJul 1Weekly roundup, 6 itemsAmgeneculizumab-aeeb